Empowering Remote Healthcare with Advanced ECG Technology
Spandan X Emcure Pharmaceuticals
Empowering Remote Healthcare with Advanced ECG Technology
In a groundbreaking initiative, Sunfox Technologies joined forces with EMCURE Pharmaceuticals to significantly
enhance cardiac care in remote regions of India. This partnership aimed to transform healthcare delivery in areas
where medical facilities were previously limited.
What We Did
The primary goal was to ensure the immediate administration of primary aid and conduct ECG tests in the event of heart attacks. This rapid response system was designed to provide critical medical support in the crucial moments following a cardiac emergency.
We focused on converting local clinics into fully equipped centres capable of managing heart attacks. This transformation involved not only the provision of Spandan ECG machines but also the necessary equipment and comprehensive training for healthcare providers.
EMCURE Pharma deployed over 220 advanced ECG machines provided by Sunfox Technologies to remote physicians and clinics. These weren't merely for testing; they were pivotal in setting up heart attack management centers in underserved regions.
The Results
In Conclusion
The collaboration between Sunfox Technologies and EMCURE Pharma has not only empowered healthcare providers with advanced technology but has also brought hope and life-saving care to thousands of patients. It stands as a testament to the power of innovation and commitment in addressing healthcare disparities.
Private: Spandan X Emcure Phramaceuticals
Spandan X LLR Meerut Medical College
Transformative Use of Spandan ECG in Cardiac Sarcoidosis Management
Diagnosis and Treatment of Cardiac Sarcoidosis using Spandan ECG
Featured in “Medical Reports and Case Studies 2023” , this case study highlights the
significant impact of the Spandan ECG device in managing a complex cardiac condition
at Lala Lajpat Rai Memorial (LLRM) Medical College, Meerut.
What We Did
A 30-year-old man under Dr. C.B. Pandey and LLRM Meerut’s cardiology team care was diagnosed with ventricular tachycardia (VT). Treatment with amiodarone restored normal sinus rhythm (NSR), but further tests, including a 2D-ECHO, revealed cardiac sarcoidosis, confirmed by elevated ACE levels.
Despite optimal care, the patient experienced recurrent VT episodes. He began using Spandan ECG for continuous monitoring, which consistently detected VT episodes. One ECG report in particular showed Wide QRS indicative of VT (LBBB Type), displaying a monomorphic pattern.
Based on the Spandan ECG data, the patient had an Automatic Implantable Cardioverter-Defibrillator (AICD) implanted for ongoing cardiac management by the LLRM Meerut cardiology team led by Dr. C.B.Pandey.
Follow-up device reports displayed a normal ECG rhythm, affirming the efficacy of AICD implantation and ongoing monitoring in managing the patient’s cardiac condition.
In Conclusion
This case, expertly managed by Dr. C.B. Pandey and the cardiology team at LLRM Meerut, demonstrates the potential of the Spandan ECG in early detection and continuous monitoring of cardiac conditions like ventricular tachycardia. The Spandan ECG provided essential data that informed treatment decisions and facilitated effective disease management, representing a breakthrough in cardiac care technology.